Campbell & Co Investment Adviser’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,877
Closed -$386K 1328
2024
Q4
$386K Sell
15,877
-3,622
-19% -$103K 0.03% 761
2024
Q3
$724K Buy
+19,499
New +$727K 0.05% 566
2024
Q1
Sell
-10,115
Closed -$316K 1351
2023
Q4
$316K Buy
+10,115
New +$363K 0.03% 897
2022
Q1
Sell
-3,650
Closed -$333K 887
2021
Q4
$333K Buy
+3,650
New +$392K 0.11% 325
2018
Q4
Sell
-6,793
Closed -$326K 490
2018
Q3
$326K Buy
+6,793
New +$278K 0.22% 191
2018
Q2
Sell
-11,780
Closed -$174K 520
2018
Q1
$174K Sell
11,780
-1,761
-13% -$27.5K 0.15% 318
2017
Q4
$210K Buy
13,541
+1,617
+14% +$24K 0.16% 306
2017
Q3
$148K Sell
11,924
-14,156
-54% -$158K 0.12% 315
2017
Q2
$282K Buy
+26,080
New +$255K 0.26% 157

Other funds holding STAA

Campbell & Co Investment Adviser's STAA Position: Q1 2025 in Review

Campbell & Co Investment Adviser sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 15,877 shares — an estimated $386K sold.

Campbell & Co Investment Adviser first reported a position in STAA in Q2 2017 and held it in 9 quarters. The position peaked at $724K in Q3 2024. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Campbell & Co Investment Adviser reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 15,877 STAAR Surgical shares in Q1 2025, an estimated $386K.
  • Campbell & Co Investment Adviser first reported a position in STAAR Surgical in Q2 2017 and held it in 9 quarters.
  • Campbell & Co Investment Adviser's STAAR Surgical position peaked at $724K in Q3 2024.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.